Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

0.6904
Delayed Data
As of 12:54pm ET
 +0.0103 / +1.51%
Today’s Change
0.61
Today|||52-Week Range
4.90
-67.12%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close0.68
Today’s open0.70
Day’s range0.68 - 0.70
Volume42,651
Average volume (3 months)725,527
Market cap$25.3M
Dividend yield--
Data as of 12:54pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-13.22%
Earnings growth (this year)+37.23%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+21.82%
P/E ratioNM
Price/Sales166.87
Price/Book1.06

Competitors

 Today’s
change
Today’s
% change
MBOTMicrobot Medical Inc-0.05-3.73%
ONCSOncoSec Medical Inc-0.02-2.04%
PTIProteostasis Therape...-0.03-1.51%
--BARD1 Life Sciences ...-0.00-33.33%
Data as of 1:08pm ET, 09/22/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$381.1K
Annual profit (last year)-$39.2M
Net profit margin-10,287.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bill Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts